Dependence of BELSOMRA® (suvorexant)
No evidence of physical dependence in clinical trials with BELSOMRA.
BELSOMRA contains suvorexant, a Schedule IV controlled substance.
Risk of misuse or abuse with BELSOMRA
Abuse of BELSOMRA poses an increased risk of somnolence, daytime sleepiness, impaired reaction time, and impaired driving skills. Patients at risk for abuse may include those with prolonged use of BELSOMRA, those with a history of drug abuse, and those who use BELSOMRA in combination with alcohol or other abused drugs.